Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$9.57 - $35.08 $94,743 - $347,292
-9,900 Reduced 7.98%
114,200 $3.36 Million
Q2 2024

Aug 14, 2024

BUY
$12.35 - $26.11 $34,580 - $73,108
2,800 Added 2.31%
124,100 $1.53 Million
Q1 2024

May 15, 2024

SELL
$18.44 - $26.41 $752,352 - $1.08 Million
-40,800 Reduced 25.17%
121,300 $2.46 Million
Q4 2023

Feb 14, 2024

BUY
$12.64 - $30.11 $881,008 - $2.1 Million
69,700 Added 75.43%
162,100 $3.65 Million
Q3 2023

Nov 14, 2023

BUY
$16.64 - $25.32 $1.31 Million - $1.99 Million
78,600 Added 569.57%
92,400 $1.54 Million
Q2 2023

Aug 14, 2023

BUY
$21.59 - $27.88 $142,494 - $184,008
6,600 Added 91.67%
13,800 $338,000
Q1 2023

May 15, 2023

BUY
$23.46 - $36.44 $168,912 - $262,368
7,200 New
7,200 $173,000
Q3 2022

Nov 14, 2022

SELL
$16.33 - $51.06 $140,437 - $439,116
-8,600 Reduced 62.32%
5,200 $217,000
Q2 2022

Aug 08, 2022

BUY
$17.22 - $38.47 $237,635 - $530,886
13,800 New
13,800 $388,000
Q1 2022

May 16, 2022

SELL
$32.6 - $53.05 $267,320 - $435,010
-8,200 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$36.77 - $90.91 $411,824 - $1.02 Million
-11,200 Reduced 57.73%
8,200 $358,000
Q3 2021

Nov 15, 2021

BUY
$41.79 - $135.3 $798,189 - $2.58 Million
19,100 Added 6366.67%
19,400 $1.2 Million
Q2 2021

Aug 16, 2021

SELL
$32.15 - $89.72 $151,105 - $421,684
-4,700 Reduced 94.0%
300 $26,000
Q1 2021

May 17, 2021

BUY
$7.09 - $87.95 $35,450 - $439,750
5,000 New
5,000 $225,000

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $101M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.